Despite these limitations, to our knowledge, this study represents one of the first to comprehensively assess OVOL1 expression in both PA and CXPA, incorporating histopathological subtypes, tumor grade, stage, capsular invasion, and recurrence. This evidence concerns the gene OVOL1 and neoplasm.